Advertisement

Topics

Biogen Ventures Into Value-Based Contracts In Multiple Sclerosis

12:24 EDT 8 Aug 2017 | SCRIP

Four contracts test approaches tying reimbursement to relapse rates and discontinuation of treatment. Payers involved include Harvard Pilgrim and Intermountain's...

      

Related Stories

 

Original Article: Biogen Ventures Into Value-Based Contracts In Multiple Sclerosis

NEXT ARTICLE

More From BioPortfolio on "Biogen Ventures Into Value-Based Contracts In Multiple Sclerosis"

Quick Search
Advertisement